Aptorum Group Highlights Further Data For ALS-4 Small Molecule Anti-Virulence Drug Candidate For Treatment of Infections Caused By Staphylococcus Aureus, On Track Targeted For Investigational New Drug Submission in 2H'20

Benzinga · 02/10/2020 13:02